Kate
CEO - USA - iCEO #95243

Experience

Senior executive in life sciences and healthcare industries (life sciences tools, bioprocessing, real world data, women` health, diagnostics), with extensive global experience in private and public companies. Successful track record in increasing shareholder value, accelerating growth, building high performance teams, innovation, fundraising, M&A, listing/uplisting and exits.

Major Achievements

Most recently, Dr. Kate Torchilin served as CEO and President of Hamilton Thorne (TSX: HTL), a leading innovator and manufacturer of products and services for IVF laboratories. Kate successfully took the company private via sale to a private equity firm, at 18x EBITDA and 62% premium to shareholders, while merging with a larger business. Prior to Hamilton Thorne, Kate was President of $1.5+ billion Biologicals and Chemicals Division at Thermo Fisher Scientific that she grew at double digits over several years.

Industry Sector Competencies

BioTech

chemicals, applied materials, healthcare

Healthcare

Private Equity

Chemical

Professional Objectives

Function: CEO, President

Interim Manager: Yes

Permanent Position: Yes

Operational: Yes

Availability: Full time, part time

Prefered Locations: Massachusetts, USA

Additional Professional Interests

Non executive director assignments

Countries Covered

Italy

South Korea

USA

Operational Competencies

AI strategy (Professional)

Technologies to market (Expert)

Business development (Expert)

Acquisition and shadow management (Expert)

New product or service launch (Expert)

Geographical expansion (Expert)

Company rescue or turnaround (Professional)

Close down or sell off (Professional)

Pre or post investment audit (Expert)